Temporal Hollowing: Why the Temples Sink, How It Affects Your Brows and Eyelids, and How Each Treatment Works

The temples are rarely the first thing a person notices when looking at their own face. They are not the cheeks, the lips, or the eyes. Yet the hollow that forms between the outer corner of the eye and the hairline quietly reshapes the entire upper face. It makes the skull visible through the skin. It drags the outer brow downward. It adds heaviness to the upper eyelid. Understanding why this happens, how it connects to the upper eyelid, and how each treatment works at the tissue level changes how both patients and surgeons approach the aging upper face.

What Temporal Hollowing Actually Looks Like

A gaunt or tired quality reads differently from simple aging. Midface deflation flattens the cheeks and deepens the nasolabial folds. Tear trough hollows cast shadows beneath the lower eyelid. Temporal hollowing does something distinct: it creates a concavity above the zygomatic arch, a scalloped indentation that makes the skull appear to press toward the skin. The shadow it casts runs from the lateral orbital rim back toward the hairline, framing the eye socket and making it appear more sunken than it is.

This is why patients often describe themselves as looking unwell rather than older. Volume loss at the cheek reads as age. Volume loss at the temple reads as illness or exhaustion - something structural is visibly gone. The distinction matters for treatment planning, because correcting only the cheeks or eyelids while the temples remain depleted leaves the most visually striking deficit untouched.

Three Hollows That Coexist in the Aging Upper Face

• Temporal hollow - the concavity above the zygomatic arch between the orbital rim and the hairline, driven by fat compartment atrophy and muscle thinning
• Lateral orbital rim depression - a shadow at the outer corner of the orbit that is often mistaken for temporal hollowing but caused by orbital fat atrophy, not temple fat loss
• Tear trough - the inferomedial orbital hollow beneath the eye, anatomically separate, addressed through different planes and products

Each has its own anatomy, its own causes, and its own treatment approach. Accurate diagnosis determines whether the treatment works.

Seven Layers and the Compartment That Actually Hollows

The temporal region is one of the most anatomically layered areas of the face. From the skin surface down to the muscle, seven distinct tissue layers are stacked in sequence:

1. Skin
2. Subcutaneous tissue
3. Superficial temporal fascia (continuous with the SMAS of the lower face)
4. Innominate fascia (a thin loose areolar layer)
5. Superficial layer of the deep temporal fascia
6. Temporal fat pad (the compartment sandwiched between the two leaves of the deep temporal fascia)
7. Deep layer of the deep temporal fascia, below which lies the temporalis muscle

The deep temporal fascia splits at the level of the superior orbital rim, creating a distinct pocket between its two leaves. That pocket - the temporal fat pad - is the compartment responsible for the visible hollow. It is not the subcutaneous fat near the skin surface. It sits deeper, between fascial layers, and it is this mid-level compartment that thins with age and atrophy.

MRI research has documented that soft tissue thickness in the temporal region decreases substantially across adulthood - one widely cited imaging study measuring women found an average decrease of approximately 3.4 mm, though the precise figure varies by study population and measurement approach. The loss is not uniform. The upper and middle portions of the temporal fat compartments thin while the lower portion, near the zygomatic arch, actually thickens slightly. This creates a characteristic scalloped concavity - a curved indentation rather than a flat depression - that distinguishes true temporal hollowing from other kinds of facial volume loss. It explains why the hollow sits where it does and why it has that distinctive curved shape.

Four Reasons the Temples Lose Volume

Normal Aging and Temporalis Thinning

The most common cause is the gradual atrophy of the temporal fat pad over time, combined with thinning of the temporalis muscle underneath. Both layers lose bulk together, which is why the change often accelerates in the fifth and sixth decades. Reduced jaw muscle use from dietary changes and the natural decline in muscle mass with age both contribute.

Weight Loss and GLP-1-Related Rapid Fat Atrophy

Rapid weight loss depletes facial fat compartments faster than gradual aging. GLP-1 receptor agonists - semaglutide and tirzepatide among them - produce a distinct presentation now widely called Ozempic face. A 2025 systematic review confirmed temporal hollowing as a major emerging cosmetic concern with these medications, driven by rapid fat atrophy rather than any direct pharmacological mechanism on the face itself. The timing matters for treatment planning: patients actively losing weight on a GLP-1 medication are not good candidates for permanent or long-lasting corrections because the baseline keeps changing. Most clinicians defer definitive treatment until weight has stabilized for several months.

Genetics

Some patients present with temporal hollowing in their twenties or early thirties, well before age-related atrophy would typically produce it. This reflects inherently thinner temporal fat pads - a structural characteristic of how a given face is built. These patients often have prominent zygomatic arches and narrow lateral facial profiles. The presentation is not a disease state, but many find it distressing and seek correction earlier than their age would suggest.

Iatrogenic Hollowing from Prior Surgery

A 2022 systematic review found that iatrogenic causes account for 63 percent of temporal hollowing cases. The most common sources are neurosurgical temporalis muscle dissection - which disrupts both the muscle and its overlying fat pad - and coronal brow lift incisions that violate the temporal fat pad during tissue dissection. This is one reason the coronal brow lift approach has been largely replaced by endoscopic and hairline incision techniques in modern brow rejuvenation. Patients who notice that their temples looked more hollow after a prior surgery are describing a well-documented and named phenomenon, not an unusual complication.

What Temple Loss Does to the Brow and Upper Eyelid

This connection is the most clinically important one for anyone being evaluated for upper blepharoplasty - and the one most treatment overviews omit entirely.

The lateral third of the brow descends first in periorbital aging. The reason is that it lacks direct frontalis muscle support. The frontalis elevates the central and medial brow; it does not extend to the outer brow. That lateral segment depends on the underlying soft tissue volume to maintain its vertical position. When the temporal fat pad thins, the outer brow loses its structural underpinning and descends.

As the brow falls, it pushes skin over the upper eyelid, creating or worsening the appearance of hooding. A patient presenting for evaluation of heavy upper eyelids may have temporal hollowing as the primary driver, a contributing factor, or no factor at all - and the distinction matters enormously for the surgical plan.

How This Changes the Pre-Operative Assessment

A 2025 study in the Journal of Cosmetic Dermatology demonstrated that filler injected into the deep temporal fat pad mechanically shifts the superficial layer of the deep temporal fascia, producing a measurable lifting effect on the lateral brow and reducing apparent upper eyelid hooding. This is a documented mechanical relationship between tissue planes, not a theoretical possibility.

In practice, restoring lateral temple volume can reduce apparent eyelid hooding enough to change the surgical plan. In some patients it eliminates the need for blepharoplasty. In others it reduces the amount of skin marked for resection. A thorough pre-operative assessment includes examining the temples, evaluating lateral brow position, and - in many cases - using a temporary filler trial to assess how much apparent eyelid heaviness resolves with volume restoration before any surgical decision is finalized. Operating on the eyelid without this assessment means the diagnosis may be incomplete.

Hyaluronic Acid Fillers: Plane, Product, and Why They Last Longer Here

The standard approach for immediate filler correction targets the deep temporal fat pad directly - the same compartment responsible for the hollow. High-density hyaluronic acid products like Voluma are placed subfascially, below the superficial layer of the deep temporal fascia, into the fat pad pocket between the two fascial leaves.

This plane has a distinctive property: material deposited here lasts significantly longer than the same product used in more mobile facial areas. Voluma in the deep temporal fat pad lasts 18 to 24 months in most patients; some clinicians report longevity approaching four years because deep subfascial placement removes the filler from the movement forces that accelerate resorption in the cheeks, lips, and other zones driven by facial expression. The temporal fat pad is a relatively static compartment. Material placed there is not worked by repetitive facial movement, so the biological degradation process proceeds more slowly.

The correction is immediate. The hollow fills from within. Because the injected material sits deep and shifts the overlying fascial layers, the effect has a structural quality - it is not simply filling a surface depression but restoring the scaffolding beneath the lateral brow. Most patients see measurable lateral brow lift alongside the volume correction.

Sculptra: Building Collagen Instead of Replacing Volume

Sculptra (poly-L-lactic acid) works through a different mechanism. Rather than replacing lost volume with a gel material, it triggers the body's own collagen synthesis around injected microparticles. The particles are gradually absorbed; the collagen framework they stimulate remains and provides the correction.

The treatment requires approximately three sessions spaced four to six weeks apart. Collagen production becomes visible over roughly 90 days after each session. Results last up to 2 years per clinical evidence, with some individual variation. The schedule is longer and the result appears more gradually than HA filler - which is a drawback for some patients and a preference for others.

Sculptra in the temporal region is placed in the subcutaneous layer and just below it - a different tissue plane than the deep temporal fat pad targeted by HA filler. This matters because the mechanism is different: biostimulation requires contact with the tissue that will produce collagen, not the isolated fat pad compartment.

Patients who tend to do well with Sculptra in the temples share some consistent characteristics:

• Gradual, diffuse volume loss rather than a sharply defined hollow
• Preference for incremental, natural-appearing change rather than immediate correction
• Comfort with multiple sessions over several months and with results that are not immediately visible
• No requirement for a reversible trial effect, since poly-L-lactic acid cannot be dissolved with hyaluronidase the way HA filler can

Comparing the Four Treatment Approaches

Autologous Fat Grafting: Harvest, Placement, and Survival

Fat grafting uses the patient's own fat, harvested by gentle liposuction from the abdomen, flanks, or thighs, processed to concentrate viable fat cells, and injected into the temporal region in small aliquots distributed across multiple tissue planes. Because the material is the patient's own tissue, there is no foreign body and no allergic risk.

Graft survival in published studies ranges from approximately 50 to 60 percent of the transferred volume, though results vary considerably with technique, processing method, and individual patient factors; the temporal region may show somewhat lower retention than other facial areas due to reduced vascularity and temporalis muscle movement. The fraction that survives establishes a blood supply, integrates into the surrounding tissue, and behaves like native fat from that point forward - it ages with the face and responds to significant weight changes over time. It does not require replacement sessions.

The reasons a surgeon typically recommends fat grafting over repeated filler sessions include:

• Significant volume deficit that would require more material than injectable filler can practically deliver in a single office session
• Patient preference for a permanent rather than temporary correction
• Concurrent surgery - many patients combine temple fat grafting with facelift or blepharoplasty, using fat harvested during the same operative session at no additional harvest burden
• Prior adverse or unsatisfying response to synthetic injectable fillers

The tradeoffs are a separate harvest procedure and a longer recovery than office injection. The unpredictability of graft survival also means some patients need a second transfer session once the initial result has fully settled, typically at three to six months.

Temporal Implants and the Hybrid Approach

Silicone temporal implants provide permanent structural augmentation. The procedure places a solid implant through a small incision within the hairline, typically performed under local anesthesia with or without sedation, and takes approximately one hour as an isolated procedure. The implant sits against the deep temporal fascia, augmenting the contour of the temporal fossa and restoring the convex profile lost to atrophy or surgical disruption.

Implants are most appropriate for patients with significant, stable temporal hollowing - particularly those with severe fat atrophy, post-surgical deficits, or genetic underdevelopment of the temporal region where the hollow reflects skeletal structure rather than soft tissue loss alone. They are not the right choice for patients whose volume is still changing from active weight loss.

A limitation of implants in isolation is the transition zone - the area where the implant edge meets the surrounding native tissue. Without additional treatment, this edge can create a visible or palpable step-off, particularly in patients with thin overlying soft tissue. The hybrid approach addresses this directly: the implant provides core structural augmentation over the deepest part of the hollow, while filler or fat grafting is used to feather the perimeter and blend the implant contour into the surrounding face. This combination produces results that neither approach achieves independently, and it has become the preferred technique among surgeons who perform a significant volume of temporal augmentation procedures.

Assessing the temporal region before finalizing an upper eyelid surgery plan is not supplementary - it is part of getting the diagnosis right. Lateral brow position depends on the tissue underneath it, and that tissue must be evaluated before the eyelid can be accurately assessed in isolation.

Vascular Safety in the Temporal Region

The temporal region carries some of the highest vascular risk of any filler injection site on the face. This reflects specific anatomy, not general caution about facial injection.

Three Structures That Determine the Risk

Three vascular structures account for the serious risks in this zone:

• Superficial temporal artery - injection into this vessel can cause retrograde embolism reaching the ophthalmic artery, with blindness as a potential outcome
• Zygomatico-orbital artery - a branch with connections to the orbital circulation; injection carries the same blindness risk as the superficial temporal artery
• Middle temporal vein - injection into this vein can cause pulmonary embolism via direct venous transport to the pulmonary circulation; this is a separate risk pathway from the arterial risks and is frequently underemphasized in patient-facing safety discussions

The middle temporal vein deserves specific attention because most published facial filler safety discussion focuses on arterial injection and the downstream risk of tissue necrosis or retrograde embolism. Venous injection in the temporal region involves a different and equally serious mechanism that has produced documented pulmonary events in the medical literature.

The Sentinel Vein and the Zone of Caution

The sentinel vein is a superficial vein visible in the anterior temporal region on many patients. Its surface location marks a dense network of perforating vessels that connect the subcutaneous plane to the middle temporal vein deeper in the tissue. The anterior half of the temporal fossa is formally designated a zone of caution in the anatomical injection literature because of this vascular density. Injection in this area carries a higher probability of inadvertent vascular contact than injection in the posterior and inferior portions of the temporal fossa.

The consensus-defined safe entry point for temporal filler is centered at the junction of the upper margin of the zygomatic arch and the lateral margin of the lateral orbital rim. This location provides access to the deep temporal fat pad while remaining at a reliable distance from the densely perforated anterior zone.

Questions to Ask Before Any Temporal Injection

Before a temporal filler session, these are reasonable questions to put to any injector:

• Which tissue plane are you targeting, and how do you confirm depth during the injection?
• Do you use aspiration before injecting? Do you use a cannula or a sharp needle, and why?
• What is your protocol if I report sudden visual changes during or immediately after the procedure?
• Is hyaluronidase stocked in this office for immediate reversal if needed?
• How many temporal injections have you performed, and what anatomical training specific to this region have you completed?

The risk of a serious vascular complication with temporal filler is low in experienced hands using correct technique and entry points. But it is not zero, and the sentinel vein is not visible on every patient. The middle temporal vein runs at variable depths. These facts are not arguments against the procedure - they are arguments for selecting a provider with specific anatomical training in this region rather than general cosmetic injection experience.

Frequently Asked Questions

Can temple filler actually reduce upper eyelid hooding without surgery?

In some patients, yes. When lateral brow descent from underlying temporal volume loss is the primary driver of apparent upper eyelid hooding, restoring that volume can lift the outer brow enough to reduce or eliminate the heaviness. This is not universal - true excess eyelid skin that exists independent of brow position still requires surgical correction. The key is accurate diagnosis before committing to either path, which is why examining the temples belongs in every upper eyelid consultation.

How does a surgeon tell whether my eyelid heaviness is from temple hollowing or from actual excess skin?

A manual brow elevation test during the examination gives a direct answer. With the outer brow gently lifted to its anatomically correct position, the surgeon assesses how much apparent eyelid skin remains. If hooding resolves substantially with brow elevation, temporal volume restoration is likely to produce a meaningful improvement. If significant skin excess persists even with the brow elevated, surgery remains appropriate regardless of what temple treatment does.

Is the temporal hollowing from semaglutide or tirzepatide permanent if I stop the medication?

Not necessarily, but partial reversal depends on whether the patient regains some weight after stopping - and many patients do not, or do not stop the medication at all. For patients remaining on GLP-1 medications long-term, the temporal hollow tends to stabilize once weight stabilizes. Definitive treatment is generally deferred until that stable point is reached, since correcting volume during active fat loss requires repeated correction as the process continues. Once stable, the treatment options are the same as for any other cause of temporal hollowing.

Why does temple filler last longer than the same filler placed in the cheeks?

Placement plane is the reason. When a high-density HA filler is injected into the deep temporal fat pad - the pocket between the two leaves of the deep temporal fascia - it sits in a structurally enclosed, relatively immobile compartment. Filler in the cheeks sits in the subcutaneous layer, where it is subject to constant movement from facial expression and chewing. Material deposited in the temporal fat pad is not degraded by that repetitive mechanical stress, which accounts for the longer clinical longevity reported consistently in this location.

What is the sentinel vein and why do injectors talk about it as a danger landmark?

The sentinel vein is a visible superficial vein in the anterior temporal region that marks a dense cluster of perforating vessels connecting the surface to the middle temporal vein deeper in the tissue. Injecting into or near these perforators carries risk of venous embolism - a complication pathway that is separate from the more widely discussed arterial risks. Its visibility on the skin surface serves as a direct warning to stay away from that zone, which is why anatomically trained injectors treat the anterior half of the temporal fossa as a formal zone of caution and approach from the posterior inferior entry point described in the injection safety consensus literature.

What is the hybrid implant-plus-filler approach and who is it for?

The hybrid approach uses a silicone temporal implant to restore the structural core of a deep hollow, then adds filler or fat grafting around the perimeter of the implant to blend its edge into the surrounding tissue. The implant handles the volume that requires permanent structural support; the injectable material handles the gradual transition zone where the implant edge would otherwise create a visible or palpable border. It is most often used for patients with severe or post-surgical hollowing where injectable treatments alone cannot provide adequate or durable core correction, but where a standalone implant would produce an unnatural edge in thinner patients.